The founder of Quarkmed graduated from Tsinghua University and Indiana University in the United States. He has held management positions in business units of several Fortune Global 500 companies and possesses over 15 years of experience in establishing and managing biopharmaceutical and CRO companies.
He serves as a member of the first council of the Radiopharmaceutical Branch of the China Isotope and Radiation Industry Association, and is an advisory member of the Expert Committee on Medical Innovation Transformation and Big Data Application of the China Productivity Society.
Graduated from Norman Bethune Health Science Center of Jilin University, majoring in clinical medicine, having 3 years of clinician experience and nearly 20 years of clinical research experience in medical devices. Used to take managerial positions in several well-known CRO companies, with many years of experience in the establishment, management, and development of medical device business units.
Major in Pharmaceutical Analysis, China Medical University, with 12 years of experience in BE, PK, PD, tolerance test project management, biological sample analysis, etc. who participated in clinical project management, method development and analytical testing of nearly 30 domestic and foreign projects.
Master of Pharmacology from China Medical University. Once worked in Kelun Pharmaceutical Co., Ltd., and participated in the clinical protocol design and IND document preparation for multiple Phase I and Phase III multicenter projects of new radiopharmaceuticals.
Graduated from Southern Medical University, and used to work in Mindray, Lifetech, and Grand Pharmaceutical Group Limited, with over 10 years of clinical research and study protocol design experience in medical devices, and devoted to active and passive class III implantable devices.
Major in chemistry of Jilin University, with 23 years of experience in new drug R&D and production, participated in the review and analysis of pre-pharmaceutical data of more than 50 clinical projects, and data analysis of test results.
With nearly 10 years of project management experience, he/she is a senior clinical management expert in the field of innovative anti-tumor drugs. He/she has rich experience in nuclear medicine and cell and gene therapy (CGT), as well as profound understanding and unique insights into nuclear medicine and cell therapy. He/she also has extensive experience in project management of hematological and solid tumor projects.
Graduated from clinical medicine, Hebei University, with 8 years of experience in medical device clinical trial projects and 1 year of experience as a clinical physician. Used to work at Johnson & Johnson and CCRF, especially in medical device field, including cardiovascular, peripheral vascular, neurological intervention, orthopedics, and AI software.
A pharmacy major in Shenyang Pharmaceutical University, familiar with the laws and regulations of GCP, FDA, NMPA; with 10 years’ experience in the supervision and management of Phase I~IV clinical trials, participated in nearly 100 clinical projects.
Major in drug analysis of Shenyang Pharmaceutical University, and has been engaged in the bioanalysis industry for 12 years. has held positions such as SD and QAM, with many years of experience in bioanalysis and project audit.
Address：Ping An Fortune Center, Lize Financial Business District of Beijing
